Autoimmune hemolytic anemia (AIHA)
Not for Routine Use
When screening requests for approval, the following information may be taken into account as there is some evidence for IG to be considered as an option.
Order Number: H17-AIHA
| Recommendations | Not recommended for routine use. May be considered one option among adjunctive therapies in urgent situations. |
| Dose/Frequency of Administration | No recommended dose or duration listed; however, expert panel recommends up to 2 g/kg divided over 2 to 5 consecutive days |